Skip to main content

Extracorporeal Membrane Oxygenation Machine Market Size to Reach USD 681.8 Million, at a 4.1% CAGR by 2030

Written by Customer Service on . Posted in Mergers And Acquisitions.

According to Fortune Business Insights, the global extracorporeal membrane oxygenation machine market size is projected to reach USD 681.8 Million in 2030, at a CAGR of 4.1% during the forecast period, 2023-2030

Pune, India, April 03, 2023 (GLOBE NEWSWIRE) — The global Extracorporeal Membrane Oxygenation (ECMO) machine market size stood at USD 495.6 million in 2022. The market is slated to grow from USD 513.3 million in 2023 to USD 681.8 million by 2030, exhibiting a CAGR of 4.1% over the estimated period. The growth is being impelled by the surging demand for long-term circulatory support in cardiac and chronic respiratory disorders.

This information is provided by Fortune Business Insights™ in its research report, titled “Extracorporeal Membrane Oxygenation (ECMO) Machine Market, 2023-2030”.

Key Industry Development:

June 2021 – ABIOMED shared plans to acquire catheter developer preCARDIA. The deal focuses on improving outcomes for acute decompensated heart failure patients.


Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/extra-corporeal-membrane-oxygenation-ecmo-market-100369


Report Scope

Report CoverageDetails
Forecast Period2023 to 2030
Forecast Period 2023 to 2030 CAGR4.1%
2030 Value ProjectionUSD 681.8 Million
Base Year2022
Market Size in 2023USD 513.3 Million
Historical Data2019 to 2021
No. of Pages125


Key Takeaways:

  • Growing need for long-term circulatory support in chronic respiratory and cardiac disorders is the major factor responsible for market growth.
  • Advancements of new products are expected to drive market growth in the coming years.
  • North America market was valued at USD 243.5 million in 2022.
  • Increasing incidence and prevalence of respiratory conditions among all age groups, are anticipated to contribute to market growth.


Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/extra-corporeal-membrane-oxygenation-ecmo-market-100369



Drivers and Restraints:

Market Growth Favored on Account of Increasing Burden of Respiratory and Cardiovascular Diseases

One of the vital factors propelling the Extracorporeal Membrane Oxygenation (ECMO) machine market growth is the growing prevalence of respiratory and cardiovascular diseases. Some of the prevalent cardiovascular diseases include cerebrovascular disease, rheumatic and congenital heart diseases, coronary heart disease, and others.

However, the market expansion is likely to be hindered due to the high cost of various ECMO procedures. These include machine costs, operator cost, and consumable costs.

Segments:

VA (Veno-Arterial) ECMO Segment Share to Surge Driven by Escalating Product Adoption

On the basis of type, the market is segmented into VV (Veno-Venous) ECMO and VA (Veno-Arterial) ECMO. The VA (Veno-Arterial) ECMO segment is poised to register considerable traction throughout the estimated period. The surge can be attributed to a range of factors, including the rising prevalence of cardiac disorders and favorable reimbursement policies.

Adult Segment to Record Notable Surge Owing to High Disease Prevalence

Based on application, the market is fragmented into pediatric, adult, and neonatal. Of these, the adult segment is estimated to record appreciable expansion over the study period. The rise is on account of an increasing number of lung transplants in this age group.

On the basis of geography, the market is categorized into North America, Europe, Latin America, Asia Pacific, and the Middle East & Africa.


Quick Buy – Extracorporeal Membrane Oxygenation Machine Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100369


Report Coverage:

The report provides a comprehensive analysis of the key factors propelling business expansion over the forecast period. It further gives an account of the major trends impelling the industry landscape throughout the estimated period. Other aspects of the report comprise the key initiatives undertaken by leading market participants to strengthen industry footing.

Regional Insights:

North America to Gain Prominence Driven by Growing Number of Surgical Procedures

The North America Extracorporeal Membrane Oxygenation (ECMO) machine market share is set to register considerable expansion over the anticipated period. The surge can be attributed to the escalating prevalence of surgical procedures in the region.

The Europe market is poised to record substantial growth throughout the forecast period. This can be credited to favorable reimbursement policies and the growing demand for healthcare devices.

Competitive Landscape:

Leading Industry Players Enter into Collaborations to Expand Product Reach

Major Extracorporeal Membrane Oxygenation (ECMO) machine participants are focused on the adoption of a range of initiatives for the consolidation of their industry position. These include collaborations, partnership agreements, and mergers. Additional steps comprise an escalation in research activities for the development and rollout of new products. 


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/extra-corporeal-membrane-oxygenation-ecmo-market-100369


List of Key Players Mentioned in the Report:

  • Getinge AB (Sweden)
  • LivaNova PLC (U.K.)
  • Medtronic (Ireland)
  • Terumo Corporation (Japan)
  • Xenios AG (Fresenius Medical Care AG & Co. KGaA) (Germany)
  • EUROSETS (Italy)
  • ABIOMED (U.S.)
  • NIPRO (Japan)
  • Spectrum Medical (U.K.)

Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
    • Market Trends
  • Key Insights
    • Number of Heart and Lung Transplantations, By Key Countries, 2022
    • New Product Launches
    • Key Industry Developments – Key Mergers, Acquisitions and Partnerships
    • Impact of COVID-19 on the Extracorporeal Membrane Oxygenation (ECMO) Machine Market
  • Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2019-2030  
    • Market Analysis, Insights and Forecast – By Type
      •  VA (Veno-Arterial) ECMO Machine
      •  VV (Veno-Venous) ECMO Machine
    • Market Analysis, Insights and Forecast – By Application
      •  Adult
      •  Pediatric
      •  Neonatal
    • Market Analysis, Insights and Forecast – By Geography
      •  North America
      •  Europe
      •  Asia Pacific
      •  Latin America
      •  Middle East & Africa
  • North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2019-2030
    • Market Analysis, Insights and Forecast – By Type
      •  VA (Veno-Arterial) ECMO Machine
      •  VV (Veno-Venous) ECMO Machine
    • Market Analysis, Insights and Forecast – By Application
      •  Adult
      •  Pediatric
      •  Neonatal
    • Market Analysis, Insights and Forecast – By Country
      • U.S.
      • Canada
  • Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2019-2030
    • Market Analysis, Insights and Forecast – By Type
      •  VA (Veno-Arterial) ECMO Machine
      •  VV (Veno-Venous) ECMO Machine
    • Market Analysis, Insights and Forecast – By Application
      •  Adult
      •  Pediatric
      •  Neonatal
    • Market Analysis, Insights and Forecast – By Country/ Sub-region
      •  U.K.
      •  Germany
      •  France
      •  Italy
      •  Spain
      •  Scandinavia
      •  Rest of Europe

TOC Continued………..

Get a Quote: https://www.fortunebusinessinsights.com/enquiry/get-a-quote/extra-corporeal-membrane-oxygenation-ecmo-market-100369


Related Reports:

Perfusion Systems Market Size, Share, Revenue Forecast and Opportunities

Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market Overview, Industry Share and Forecast

Intensive Care Unit (ICU) Equipment Market Size, Share, Opportunities & Analysis

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. 

Contact Us:

Fortune Business Insights Pvt. Ltd.

9th Floor, Icon Tower, Baner – Mahalunge Road,

Baner, Pune-411045,

Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.